Coronavirus / COVID

The agency is making the safe return to school in the fall their top priority.

The announcement aligns with an FDA and CDC statement against the need for booster doses.

Kansas counties that adopted mask mandates saw a 60% drop in COVID-19 cases, a new study found.

In the second installment of an interview, members of the FlowMetric Life Sciences' leadership discuss how their technology might aid possible COVID-19 vaccine booster shots, how immunocompromised patients respond to vaccines, and other vaccines where their platform may be used.

The Sinovac developed vaccine could greatly aid in the global inoculation effort.

A study looked at COVID-19 incidence rates in health care workers who wore medical masks vs respirator masks when performing nonaerosolizing, routine patient care.

Two doses of the Pfizer or AstraZeneca vaccines generated high sero-neutralization against the strain.

While the efficacy of SARS-CoV-2 vaccines have been demonstrated, a lack of data is present for patients with cancer.

FlowMetric, Inc., discusses its VaxEffect, an immune monitoring platform and how it can be used to measure COVID-19 vaccine responses.

Benefits were also observed among adults aged 18 to 49, with adults over 65 seeing the most benefit.

Research has shown that some receptors for the virus are linked to male hormones.

Patients receiving both IL-6 and corticosteroids showed lower risks of death and mechanical ventilation.

New study finds differences in testing, disease severity in England.

A single dose of mRNA vaccine proved 81% effective against a SARS-CoV-2 infection.

Testing every 3 days showed a test sensitivity of 98%.

The therapy demonstrated an efficacy of 65.2% against the Delta variant.

New data suggest countries with limited vaccine supplies may not need to immediately vaccinate all members of low-risk households.

Brain tissue in people who died of SARS-CoV-2 look suspiciously like that of people with various forms of dementia and other neurocognitive conditions.

With millions of people facing long-term COVID-19 conditions, the CDC issued interim guidance on evaluation and care.

The activity was higher than what was recently observed for the South African variant.

94% of the participants in the study developed COVID-19 antibodies.

Unvaccinated healthcare workers showed similar levels of antibodies to vaccinated ones.

COVID-19-associated hospitalization of adolescents is more than 12 times less likely than that of adults, but exceeds that associated with influenza by 2.5 to 3 times, the US Centers for Disease Control and Prevention (CDC) reported.

AFHs reported concerns such as staff coming to work sick and lack of PPE.

IPs experienced PPE shortages, high levels of stress and emotional exhaustion.

The Sinovac developed vaccine generated antibodies against SARS-CoV-2 in a phase 1/2 trial.

The CAD demonstrated excellent sustained antiviral activity against the test pathogen.

Communal gathering areas were found to be a major source of exposure.

During the pandemic, one regional health system looked at the age distribution of the virus and hospitalization and mortality rates.

AstraZeneca’s COVID-19 vaccine was safe and immunogenic for people with HIV who are well-controlled on antiretroviral therapy, a study has shown.